|
|
|
|
|
Recent publications This page gives details of some of the peer-reviewed papers and books which Mr Muir has published, and some of the presentations at medical meetings Original Research Papers Agha R, Cooper D, Muir G. The reporting quality of randomised
controlled trials in surgery: a systematic review. Int J Surg. 2007 Dec;5(6):413-22.
Epub 2007 Oct 29. Review. Gómez Sancha F, Bachmann A,
Choi BB, Tabatabaei S, Muir GH. Photoselective vaporization of the
prostate (GreenLight PV): lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis.
2007;10(4):316-22. Epub 2007 Jul 10. Bilagi P, Sriprasad S, Clarke JL,
Sellars ME, Muir GH, Sidhu PS. Clinical and ultrasound features of
segmental testicular infarction: six-year experience from a single centre. Eur Radiol. 2007 Nov;17(11):2810-8.
Epub 2007 Jul 5. Rajbabu K, Barber NJ, Choi W, Muir
GH. To knot or not to knot? Sutureless
haemostasis compared to the surgeon's knot. Ann R Coll Surg Engl. 2007
May;89(4):359-62. Rajbabu K, Chandrasekara SK, Barber
NJ, Walsh K, Muir GH. Photoselective vaporization of the
prostate with the potassium-titanyl-phosphate laser in men with prostates of >100
mL. BJU Int. 2007 Sep;100(3):593-8;
discussion 598. Epub 2007 May 19. Carey AM, Pramanik R, Nicholson LJ,
Dew TK, Martin FL, Muir GH, Morris JD. Ras-MEK-ERK signaling cascade regulates
androgen receptor element-inducible gene transcription and DNA synthesis in
prostate cancer cells. Int J Cancer. 2007 Aug
1;121(3):520-7. Rajbabu K, Chandrasekera S, Zhu G,
Dezylva S, Grunfeld EA, Muir GH. Racial origin is associated with poor
awareness of prostate cancer in UK men, but can be increased by simple
information. Prostate Cancer Prostatic Dis.
2007;10(3):256-60. Epub 2007 Mar 20. Ben-Shlomo Y, Evans S, Ibrahim F,
Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D,
Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R; PROCESS study group. The risk of prostate cancer amongst
black men in the United Kingdom: the PROCESS cohort study. Eur Urol. 2008 Jan;53(1):99-105. Epub
2007 Mar 1. Liu M, Rajbabu K, Zhu G, Petersen A,
Muir GH, Poulson J. Laparoscopic partial nephrectomy with
saline-irrigated KTP laser in a porcine model. J Endourol. 2006 Dec;20(12):1096-100. Rajbabu K, Dudderidge T, Barber N,
Walsh K, Muir G. Evaluation of ideal irrigation fluid in
'Greenlight' photoselective vapourization of the prostate. Prostate Cancer Prostatic Dis.
2007;10(1):101-3. Epub 2006 Oct 10.
Beliefs about illness and quality of life among
men with erectile dysfunction. Stamogiannou I, Grunfeld EA, Int J Impot Res. 2005 Mar-Apr;17(2):142-7.
The efficacy of sildenafil for the treatment of
erectile dysfunction in male peritoneal dialysis patients. Am J Kidney Dis. 2005 Feb;45(2):381-7. Phentolamine re-dosing during penile dynamic
colour Doppler ultrasound: a practical method to abolish a false diagnosis of
venous leakage in patients with erectile dysfunction. Gontero P, Sriprasad S, Wilkins CJ, Donaldson N,
Muir GH, Sidhu PS. Br J Radiol. 2004 Nov;77(923):922-6. Development of bladder urothelial hyperplasia and
carcinoma in portacaval shunted rats is not dependent upon urolithiasis. Alexander B, Makar AA, Hopster D, O'Donnell PJ,
Coptcoat MJ, Muir G. Exp Mol Pathol. 2004 Dec;77(3):205-9. Acquiring surgical skills: a comparative study of
open versus laparoscopic surgery. Subramonian K, DeSylva S, Bishai P, Thompson P,
Muir G. Eur Urol. 2004 Mar;45(3):346-51; Reduction of TSG101 protein has a negative impact
on tumor cell growth. Zhu G, Gilchrist R, Borley N, Chng HW, Morgan M,
Marshall JF, Camplejohn RS, Muir GH, Hart IR. Int J Cancer. 2004 Apr 20;109(4):541-7. Laparoscopic pelvic lymph node dissection allows
significantly more accurate staging in "high-risk" prostate cancer
compared to MRI or CT. Borley N, Fabrin K, Sriprasad S, Mondaini N,
Thompson P, Muir G, Poulsen J. Scand J Urol Nephrol. 2003;37(5):382-6. Sildenafil does not improve sexual function in
men without erectile dysfunction but does reduce the postorgasmic refractory
time. Mondaini
N, Ponchietti R, Muir GH, Montorsi F, Di Loro F, Lombardi G, Rizzo M. Int J Impot Res. 2003 Jun;15(3):225-8. Ex vivo chemosensitivity to mitomycin C in
bladder cancer and its relationship with P-glycoprotein and apoptotic
factors. Gontero P, Sargent JM, Hopster DJ, Lewandowic GM,
Taylor CG, Elgie AW, Williamson CJ, Sriprasad SI, Muir GH. Anticancer Res. 2002 Nov-Dec;22(6C):4073-80. Primary cultures of prostate cells and their
ability to activate carcinogens. Martin FL, Cole KJ, Muir GH, Kooiman GG, Williams
JA, Sherwood RA, Grover PL, Phillips DH. Prostate Cancer Prostatic Dis. 2002;5(2):96-104. Penile length is normal in most men seeking
penile lengthening procedures. Mondaini
N, Ponchietti R, Gontero P, Muir GH, Natali A, Caldarera E, Biscioni S, Rizzo
M. Int J Impot Res. 2002 Aug;14(4):283-6. Identification of potential diagnostic markers of
prostate cancer and prostatic intraepithelial neoplasia using cDNA
microarray. Bull JH, Ellison G, Patel A, Muir G, Walker M,
Underwood M, Khan F, Paskins L. Br J Cancer. 2001 Jun 1;84(11):1512-9. Validity of PSA, free/total PSA ratio and
complexed/total PSA ratio measurements in men with acute urinary
retention. Sriprasad S, Dew TK, Muir GH, Thompson PM, Mulvin
D, Choi WH, Dickinson IK, Sherwood RA. Prostate Cancer Prostatic Dis. 2001;4(3):167-172.
An appraisal of telomerase activity in benign
prostatic hyperplasia. Caldarera
E, Crooks NH, Prostate. 2000 Nov 1;45(3):267-70. Penile fracture repair: assessment of early
results and complications using color Doppler ultrasound. Gontero
P, Sidhu PS, Muir GH. Int J Impot Res. 2000
Apr;12(2):125-8; discussion 128-9. Metabolic activation of carcinogens and
expression of various cytochromes P450 in human prostate tissue. Williams JA, Martin FL, Muir GH, Hewer A, Grover
PL, Phillips DH. Carcinogenesis. 2000 Sep;21(9):1683-9. Evaluation of P53 protein overexpression, Ki67
proliferative activity and mitotic index as markers of tumour recurrence in
superficial transitional cell carcinoma of the bladder. Gontero
P, Casetta G, Zitella A, Ballario R, Pacchioni D, Magnani C, Muir GH, Tizzani
A. Eur Urol. 2000
Sep;38(3):287-96. Orthotopic bladder substitution by detubularized
sigmoid using a new method of neovesico-urethral anastomosis. Grasset D, Delbos O, Muir GH, Robert M, Guiter J.
Br J Urol. 1998 Apr;81(4):623-7. Piezoelectric extracorporeal shock-wave
lithotripsy of lower pole nephrolithiasis. Robert M,
Marotta J, Rakotomalala E, Muir G, Grasset D. Eur Urol. 1997;32(3):301-4. Detection of telomerase activity in human
prostate: a diagnostic marker for prostatic cancer? Scates DK, Muir GH, Venitt S, Br J Urol. 1997 Aug;80(2):263-8. Video-resection does not stop corneal
contamination during transurethral resection of the prostate. Muir GH, Davies JH. Br J Urol. 1996 Jun;77(6):836-8. Management of major blunt renal lacerations:
surgical or nonoperative approach? Robert M,
Drianno N, Muir G, Delbos O, Guiter J. Eur Urol. 1996;30(3):335-9. Vacuolation in prostate cancer cells following
luteinizing hormone releasing hormone analogue treatment. Muir GH, Shearer RJ, Dearnaley DP, Fisher C. Br J Urol. 1994 Mar;73(3):268-70. Induction of transforming growth factor beta in
hormonally treated human prostate cancer. Muir GH, Butta A, Shearer RJ, Fisher C, Dearnaley
DP, MB,
Colletta AA. Br J
Cancer. 1994
Jan;69(1):130-4. Review Articles Chandrasekera S, Muir G. Potassium titanyl phosphate laser
prostatectomy: a review. Curr Opin Urol. 2007 Jan;17(1):22-6.
Review. The 'learning curve' in surgery: what is it, how
do we measure it and can we influence it? Subramonian K, Muir G. BJU Int. 2004 Jun;93(9):1173-4. High-power KTP laser prostatectomy: the new
challenge to transurethral resection of the prostate. Curr Opin Urol. 2004 Jan;14(1):21-5.. Does laparoscopic surgery spell the end of the
open surgeon? Agha R, Muir G. J R Soc Med. 2003 Nov;96(11):544-6. Pathological findings of penile fractures and
their surgical management. Gontero
P, Muir GH, Frea B. Urol Int. 2003;71(1):77-82. The influence of dietary and environmental
factors on prostate cancer risk Kooiman GG, Martin FL, Williams JA, Grover PL,
Phillips DH, Muir GH. . Prostate Cancer Prostatic Dis. 2000
Dec;3(4):256-258. The genetic alterations in the oncogenic pathway
of transitional cell carcinoma of the bladder and its prognostic value. Gontero
P, Tizzani A, Muir GH, Caldarera E, Macaluso MP. Urol Res. 2001 Dec;29(6):377-87. Review. The role of immunotherapy for urological
tumours. Hrouda D, Muir GH, Dalgleish AG. Br J Urol. 1997 Mar;79(3):307-16 Prostate
cancer. Dearnaley,
D. P; Price, A.; Shearer, R. J; Chamberlain, J; Melia, J,.Eeles, R; Stratton,
M, Muir, G. Jarman, M. Lancet. 342(8876):901-905, October 9, 1993. G.H.Muir. Formation des
Urologues dans l’Europe. Uro
Jonction ( Prostate Cancer. G.H. Muir, R. J. Shearer. Postgraduate Surgery (1994), 12, 76-80. Books and Chapters The Evidence for Urology (co-Editor with C
Dawson) TFM Publishing, London 2005 New alternatives to TURP. In: Private Hospital Healthcare Case series and short reports Splenogonadal fusion: B-mode and color Doppler
sonographic appearances Stewart VR, Sellars ME, Somers S, Muir GH, Sidhu
PS. J Ultrasound Med. 2004 Aug;23(8):1087-90. Impalpable testis cancer. Sidhu PS, Sriprasad S, Bushby LH, Sellars ME,
Muir GH. BJU Int. 2004 Apr;93(6):888. Screening for renal cell carcinoma using
ultrasonography: a feasibility study Zhan
X, Sidhu PS, Muir GH. BJU Int. 2003 Dec;92(9):1047-8. An unusual cause of voiding dysfunction following
colposuspension Robinson D, Bidmead J, Cardozo L, Muir G. . J Obstet Gynaecol. 2003 Mar;23(2):210-1. Can diet affect prostate cancer? BJU Int. 2002 Jul;90(1):141;. A 10-year experience of managing ureteric
calculi: changing trends towards endourological intervention--is there a role
for open surgery? Choi W, Poulsen J, Muir G. BJU Int. 2002 May;89(7):792. Laparoscopic removal of multicystic dysplastic
pelvic kidney Sriprasad S, Poulsen J, Muir G, Kane P, Coptcoat
MJ. J Endourol. 2001 Oct;15(8):805-7. Review. Acute segmental testicular infarction:
differentiation from tumour using high frequency colour Doppler ultrasound. Sriprasad S, Kooiman GG, Muir GH, Sidhu PS. Br J Radiol. 2001 Oct;74(886):965-7. Mean time to cancer-specific death of apparently
clinically localised prostate cancer: policy implications for threshold ages
in prostate-specific antigen and ablative therapy. Kooiman GG, Muir G. BJU Int. 2001 Jan;87(1):128-9. Is prostate-specific antigen a reliable marker of
bone metastasis in patients with newly diagnosed cancer of the prostate? Gontero
P, Muir GH. Eur
Urol. 1998 Dec;34(6):518-9.
Gastric carcinoma presenting with testicular
metastasis. Muir GH, Fisher C. Br J Urol. 1994 Jun;73(6):713-4. No abstract
available. Selected Recent Presentations (with published
abstracts) American Urological Association Meeting 2005 A
randomized controlled, single blind study to assess the effectiveness of a
cardboard box as a tool for laparoscopy training. CHANDRASEKERA,
S. K.; SHAH, N.; DE ZYLVA, T. S.U.; BISHAI, P.; DONOHUE, J.; MUIR, G. H
BJU International - Supplement. 93 Supplement 4:77, June 2004. European
Association of Urology Meeting 2005 Urological
Research Society, 2004: Do
patients with prostate cancer and their carers have a realistic knowledge of
the epidemiology of prostate cancer?. EVANS, S.; ANSON, K. ; CHINEGWUNDOH, F,
CORBISHLEY, C, KIRBY, R, MUIR, G., GILLATT, D, PATEL, B, POPERT, R,
PERSAD, R, BEN-SHLOMO, Y BJU
International. 94(7):1169-1170, November 2004. The
effect of adding lycopene on primary prostate cell lines. ZHANG, XIN; BARBER,
NEIL; ZHU, GANG; PRAMANIK, RASHIDA; MARTIN, FRANCIS *; MORRIS, JONATHAN;
WALSH, KILIAN; MUIR, GORDON BJU International. 94(7):1165, November 2004.
British Prostate Group Meeting: 2004 ' British Urological Association meeting , 2004 Selective
angio-embolization in severe renal trauma - a single centre experience. CHANDRASEKERA,
S. K.; WILKINS, C. J.; WALSH, K.; MUIR, G. H.; WALTERS, H. L.; THOMPSON, P.
M. BJU International - Supplement. 93 Supplement 4:103-104, June 2004.
Laparoscopic
nephrectomy - a retrospective review of 111 cases. EDDY, B. *; DONOHUE, J. *;
BARBER, N. *; MUIR, G. *; POULSEN, E. U. +; POULSEN, J. BJU International
- Supplement. 93 Supplement 4:77-78, June 2004. A
randomized controlled, single blind study to assess the effectiveness of a
cardboard box as a tool for laparoscopy training. CHANDRASEKERA,
S. K.; SHAH, N.; DE ZYLVA, T. S.U.; BISHAI, P.; DONOHUE, J.; MUIR, G. H
BJU International - Supplement. 93 Supplement 4:77, June 2004. A
dedicated weekly clinic can reduce urological emergency admissions. CALLEN,
C.; BARBER, N. J.; CHANDRASEKERA, S.; WALSH, K.; THOMPSON, P. M.; MUIR, G. H.
BJU International - Supplement. 93 Supplement 4:52, June 2004. British Prostate Group Meeting: 2003 Serum
Her-2/neu in prostatic disease. Borley, N C; Choi, W H; Tumour
marker M2-PK in prostate disease. Borley, N C; Choi, W H; Dew, T K;
Sriprasad, S; Thompson, P M; Sherwood, R A; Muir, G H Prostate Cancer
& Prostatic Diseases. 6(1):93-94, 2003. British Urological Association Meeting , 2003 To
knot or not to knot? Sutureless haemostasis compared with the surgeon's knot.
CHOI, W. H.; BARBER, N. J.; POULSEN, J.; THOMPSON, P. M.; MUIR, G. H. BJU
International - Supplement. 91 Supplement 2:12-13, June 2003. Acquiring
surgical skills: is the 'learning curve' different for open surgery and
laparoscopy?. SUBRAMONIAN, K.; De SYLVA, S.; BISHAI, P.; THOMPSON,
P.; MUIR, G. BJU International - Supplement. 91 Supplement 2:9, June 2003.
Scandanavian Urological Association Meeting , 2003 LAPAROSCOPIC
NEPHRECTOMY/NEPHROURETERECTOMY. THREE YEARS SINGLE-CENTRE EXPERIENCE.
Poulsen, E. U.; Donohue, J. O.; Muir, G.; Poulsen, J. Scandinavian Journal
of Urology & Nephrology Supplementum. 37 Supplement 214:19-20, 2003.
Societe INternationale d’Urologie Meeting , 2002 Availability
of herbal medicine for prostate cancer. Choi, W. H.; Mayer, E.; Sriprasad,
S.; Thompson, P. M.; Muir, G. H. BJU International - Supplement. 90
Supplement 2:263, September 2002. Black
British men develop prostate cancer younger than white men: results of pilot
study. Choi, W. H.; Hall, W.; Sriprasad, S.; Poulsen, J.; Thompson, P. M.;
Muir, G. H. BJU International - Supplement. 90 Supplement 2:187-188,
September 2002. Tumour
marker M2 type pyruvate kinase in prostate disease. Borley, N. C.; Choi, W.
H.; Dew, T. K.; Sriprasad, S.; Thompson, P. M.; Sherwood, R. A.; Muir, G. H. BJU
International - Supplement. 90 Supplement 2:159, September 2002. Copyright (c) 1999-2001 GH Muir. All rights reserved. |